tert-butyl((3,4-dihydro-2H-pyran-2-yl)methoxy)diphenylsilane | 873309-58-1

• 分子结构分类: 有机化合物 - 有机金属化合物 - 有机类金属化合物
• 英文名称: tert-butyl((3,4-dihydro-2H-pyran-2-yl)methoxy)diphenylsilane
• 英文别名: 2-[[[(1,1-Dimethylethyl)diphenylsilyl]oxy]methyl]-3,4-dihydro-2H-pyran；tert-butyl-(3,4-dihydro-2H-pyran-2-ylmethoxy)-diphenylsilane
• CAS: 873309-58-1
• 化学式: C₂₂H₂₈O₂Si
• 分子量: 352.549
• InChiKey: HTDPDIAHZSKORB-UHFFFAOYSA-N

物化性质

• 沸点：
  416.5±28.0 °C(Predicted)
• 密度：
  1.04±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.26
• 重原子数：
  25
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.36
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  tert-butyl((3,4-dihydro-2H-pyran-2-yl)methoxy)diphenylsilane 在 偶氮二甲酸二异丙酯 、 dimethyl sulfide borane 、 potassium carbonate 、 一水合肼 、 三苯基膦 作用下， 以 四氢呋喃 、 甲醇 、 乙腈 为溶剂， 反应 7.0h， 生成 ethyl 4-((6-(((tert-butyldiphenylsilyl)oxy)methyl)tetrahydro-2H-pyran-3-yl)amino)-2-chloropyrimidine-5-carboxylate
  参考文献：
  名称：

  IMIDAZOLINONE DERIVATIVE AND USE THEREOF IN MEDICINE

  摘要：

  本申请涉及咪唑烷酮衍生物及其医药用途，特别是涉及由一般式(I)表示的嘧啶衍生物，或者其立体异构体、溶剂化物、代谢物、前药、药学上可接受的盐或共晶，包含所述化合物的药物组合物，以及根据本申请的化合物或药物组合物在制备用于治疗癌症的药物中的用途。

  公开号：

  EP4137491A1
• 作为产物：
  描述：

  3,4-二氢-2H-吡喃-2-甲醛 在 咪唑 、 sodium tetrahydroborate 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 为溶剂， 反应 7.0h， 生成 tert-butyl((3,4-dihydro-2H-pyran-2-yl)methoxy)diphenylsilane
  参考文献：
  名称：

  Design, synthesis, and preliminary SAR study of 3- and 6-side-chain-extended tetrahydro-pyran analogues of cis- and trans-(6-benzhydryl-tetrahydropyran-3-yl)-benzylamine

  摘要：

  In our effort to further understand interaction of novel pyran derivatives with monoamine transporters, we have designed, synthesized, and biologically characterized side-chain-extended derivatives of our earlier developed cis- and trans-(6-benz-hydryl-tetrahydro-pyran -3-yl)-benzylamine derivatives. Both 3- and 6-position extensions were explored. All synthesized derivatives were tested for their affinities for the dopamine transporter (DAT), serotonin transporter (SERT), and norepinephrine transporter (NET) in the brain by measuring their potency in inhibiting the uptake of [H-3]DA, [H-3]5-HT, and [H-3]NE, respectively. Compounds were also tested for their binding affinity at the DAT by their ability to inhibit binding of [H-3]WIN 35, 428. The results indicated that extension at the 3-position resulted in loss of activity compared to the original compound 1. Oil the other hand, extension at the 6-position resulted in improvement of activity in the compound cis-12 by 2-fold over the parent compound 1 indicating favorable interaction. In addition, two glycoside derivatives were designed, synthesized, and biologically characterized. The glycosidic trans-isomer 24 exhibited highest potency for the NET in the current series of compounds. (c) 2006 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2006.01.051

文献信息

• [EN] AMINO-PYRROLOPYRIMIDINONE COMPOUNDS AND METHODS OF USE THEREOF<br/>[FR] COMPOSÉS AMINO-PYRROLOPYRIMIDINONE ET LEURS PROCÉDÉS D'UTILISATION
  申请人：ARQULE INC

  公开号：WO2018039310A1

  公开（公告）日：2018-03-01

  The application relates to a compound of Formula (I): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, which modulates the activity of BTK, a pharmaceutical composition comprising a compound of Formula (I), and a method of treating or preventing a disease in which BTK plays a role.

  该申请涉及式(I)的化合物：或其药物可接受的盐、水合物、溶剂化物、前药、立体异构体或互变异构体，其调节BTK的活性，一种包含式(I)化合物的药物组合物，以及一种治疗或预防BTK发挥作用的疾病的方法。
• Nickel catalyzed dealkoxylative C_sp2–C_sp3 cross coupling reactions – stereospecific synthesis of allylsilanes from enol ethers
  作者：Lin Guo、Matthias Leiendecker、Chien-Chi Hsiao、Christoph Baumann、Magnus Rueping

  DOI：10.1039/c4cc08187k

  日期：——

  The application of cyclic and acyclic enol ethers as electrophiles in cross coupling reactions offers new possibilities for the preparation of functional compounds.

  环状和非环状烯醇醚作为亲电试剂在交叉偶联反应中的应用为功能化合物的制备提供了新的可能性。
• 酰胺类衍生物、其制法与医药上的用途
  申请人：上海海雁医药科技有限公司

  公开号：CN110105275B

  公开（公告）日：2020-12-29

  本发明涉及酰胺类衍生物、其制法与医药上的用途。具体地，本发明公开了式(I)化合物或其药学上可接受的盐、或立体异构体，及其制备方法和应用，式中各基团的定义详见说明书。
• Palladium mediated spiroketal synthesis: application to pheromone synthesis
  作者：Jeremy C. Conway、Peter Quayle、Andrew C. Regan、Christopher J. Urch

  DOI：10.1016/j.tet.2005.09.055

  日期：2005.12

  Stereospecific Stille coupling reactions of 2-metallo-dihydropyrans with Z-vinyl iodo alcohols and subsequent cyclisation provides rapid access to 1,7-dioxaspiro[5.5]undecane family of spiroketals.

  2-金属二氢吡喃与Z-乙烯基碘醇的立体特异性Stille偶联反应及随后的环化作用可快速获得1,7-二氧杂螺[5.5]十一烷螺环家族。
• 2-Trifluoromethylthiolation of glycals
  作者：Yang Yu、De-Cai Xiong、Xin-Shan Ye

  DOI：10.1039/c6ob01001f

  日期：——

  Methods for trifluoromethylthiolation are very limited. To tackle this problem, a mild and efficient approach to the 2-trifluoromethylthiolation of glycals has been developed. This protocol employed N-trifluoromethylthiosaccharin as the trifluoromethylthiolating reagent, TMSCl as the activator, and DBU as the base, affording 2-trifluoromethylthioglycals in good yields. These trifluoromethylthiolated

  三氟甲基硫醇化的方法非常有限。为了解决这个问题，已经开发了温和而有效的方法用于对糖基进行2-三氟甲基硫醇化。该方案使用N-三氟甲基硫代糖精作为三氟甲基硫醇化试剂，TMSC1作为活化剂，DBU作为碱，以高收率得到2-三氟甲基硫代糖醛。这些三氟甲基硫醇化的碳水化合物可能有益于基于碳水化合物的药物的开发。